EPHA1 and cancer: Originally characterized as axon guidance regulators, ephrins and Eph RTKs regulate physiologic and pathologic processes during embryonic development, in normal tissue homeostasis, and in disease [reviewed in [5], [6], [9]], making them attractive candidates for new molecularly targeted therapies, particularly in cancer.